COMMUNIQUÉS West-GlobeNewswire

Kane Biotech Provides Further Corporate Update
18/06/2025
WINNIPEG, Manitoba, June 18, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”) provides updates on its reorganizational phase. The Company has terminated its exclusive [...]
BrightSpring Health Services Announces Onco360® Selected as National Pharmacy Partner for Multiple New Cancer and Rare Disease Drugs
18/06/2025
LOUISVILLE, Ky., June 18, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services (“BrightSpring” or “BrightSpring Health Services”) (NASDAQ: BTSG) is proud to announce that its specialty pharmacy, Onco360® , has been [...]
Cellectar Biosciences Announces One-for-Thirty Reverse Stock Split
18/06/2025
FLORHAM PARK, N.J., June 18, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of [...]
Annexon Bolsters Ophthalmology Expertise with Appointment of Retina Specialist Lloyd Clark, M.D., as Pivotal ANX007 Program Advances in Dry Age-Related Macular Degeneration (AMD) with Geographic Atrophy (GA)
18/06/2025
Dr. Clark Brings 25 Years of Experience Treating Retina Diseases and Developing Emerging Therapies as a Principal Investigator in Over 70 Clinical Trials and as an Early Pioneer of VEGF Inhibitors ANX007 is the Only [...]
Vincerx Pharma, Inc. Announces Adjournment of Special Meeting - Will Reconvene Meeting on July 16, 2025 to Secure Votes Needed to Approve Dissolution Proposal
18/06/2025
Failure to approve Dissolution Proposal will reduce or eliminate any potential distributions to stockholders SAN MATEO, Calif., June 18, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (OTC Pink: VINC) today announced [...]
Galapagos Presented New Data at ICML 2025 From Cohort 3 of ATALANTA-1 in Relapsed/Refractory Indolent NHL Patients, Demonstrating High Complete Response and MRD Negativity Rates With CAR-T Candidate GLPG5101
18/06/2025
Of the 34 patients enrolled in Cohort 3 of the ATALANTA-1 Phase 1/2 study, 32 received GLPG5101; 94% were infused with fresh CAR-T cells, and 93% were treated within seven days of manufacturing GLPG5101 demonstrated [...]
OnlineSemaglutide.org Launches Platform Offering Easy Access to GLP-1 Medications
18/06/2025
Revolutionizing Access to Modern Weight-Care Solutions San Diego, CA, June 18, 2025 (GLOBE NEWSWIRE) -- OnlineSemaglutide.org, a leader in the field of Health & Medicine, Women's Health, and Men's Health, is [...]
Excellent Brain Ltd. Announces Joint Venture with MasNeuros to Launch Spanish Neurofeedback Trainers Course
18/06/2025
Excellent Brain Ltd. Expands Global Reach with Spanish Neurofeedback Course Natanya, Israel , June 18, 2025 (GLOBE NEWSWIRE) -- Excellent Brain Ltd., an innovative Israeli start-up renowned for its advanced [...]
Life Backup Plan App by Galacxia, Inc. Recognized for Great Potential in Pepperdine’s Most Fundable Companies Competition
18/06/2025
Aliso Viejo, CA , June 18, 2025 (GLOBE NEWSWIRE) -- Galacxia, Inc ., developer of the Life Backup Plan digital health platform , proudly announces its advancement to the second round of Pepperdine University’s Most [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 mai 2025
18/06/2025
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 mai 2025 En application de l'article L. 233-8 II du code de commerce et de l'article 222-12-5 du règlement général de l'AMF, les [...]
Zealand Pharma announces positive topline results from 28-week Phase 1b trial with GLP-1/GLP-2 receptor dual agonist dapiglutide
18/06/2025
Company announcement – No. 15 / 2025 Zealand Pharma announces positive topline results from 28-week Phase 1b trial with GLP-1/GLP-2 receptor dual agonist dapiglutide Body weight reductions of a mean of 11.6% after 28 [...]
Human Appeal announces summertime UK Comedy Tour
18/06/2025
MANCHESTER, United Kingdom, June 18, 2025 (GLOBE NEWSWIRE) -- Following the roaring success of its annual winter Comedy Tour over the last decade, one of the UK’s leading humanitarian aid charities, Human Appeal, today [...]
Bay Area Lyme Foundation Announces New Executive Director Josh Wein
18/06/2025
Wein brings valuable life sciences and fundraising experience to advance BAL's mission PORTOLA VALLEY, Calif., June 18, 2025 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation , a leading sponsor of Lyme disease research in [...]
Bioxytran Secures a Source of GMP Quality Camel Hemoglobin
18/06/2025
- First use of camel hemoglobin as a universal oxygen carrier - Unique properties make it an ideal ingredient for oxygen transport BOSTON, MASSACHUSETTS, June 18, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) ( [...]
Eolo Pharma Publishes First-in-Human Study in Nature Metabolism on Novel Obesity Drug Activating Energy-Burning Pathway
18/06/2025
- New data show clinical safety and early efficacy of SANA, a first-in-class compound that targets creatine-dependent thermogenesis MONTEVIDEO, Uruguay, June 18, 2025 (GLOBE NEWSWIRE) -- Eolo Pharma , a clinical-stage [...]
BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Compelling BRTX-100 Clinical Data, Leadership Enhancements and Strategic updates
18/06/2025
MELVILLE, N.Y., June 18, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc . (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ: BRTX ) , a clinical stage regenerative medicine innovator focused on stem cell-based [...]
Hairmax Partners with Truemed to Accept FSA/HSA Payments on FDA-Cleared Laser Hair Growth Devices
18/06/2025
Medical-Grade Hair Growth Devices Now Eligible for Pre-Tax Funds Boca Raton, FL, June 18, 2025 (GLOBE NEWSWIRE) -- Medical-Grade Hair Growth Devices Now Eligible for Pre-Tax Funds Hairmax, the global leader in laser [...]
Orchestra BioMed Showcases AVIM Therapy as Purpose-Built Solution for Hypertensive Heart Disease at CSI Frankfurt 2025
18/06/2025
Presentation underscores unique potential for atrioventricular interval modulation (“AVIM”) therapy to manage blood pressure in older, high-risk patients who have indicators of diastolic dysfunction and progression to [...]
Outlook Therapeutics to Participate in a Virtual Investor Lunch Break Event
18/06/2025
Live webcast on Wednesday, June 25th at 12:00 PM ET ISELIN, N.J., June 18, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for [...]

Pages